59 results on '"Iwamatsu K"'
Search Results
2. Chemical Effects of Ionizing Radiation on Molten Salt Systems
3. Sequential radiation chemical reactions in aqueous bromide solutions: pulse radiolysis experiment and spur model simulation
4. Frequency-doubled vortex laser based on a side-pumped Nd:YVO4 compact stigmatic bounce amplifier
5. Radially-polarized, Q-switched pulses from a side-pumped Nd:YVO4 compact stigmatic bounce laser with a photonic crystal output coupler
6. Concentration and Incident Energy Dependences of Transient Species in Water by H+ Ion Irradiation
7. ChemInform Abstract: Synthetic Cephalosporins. Part 6. Synthesis and Antibacterial Activity of 7-(Z-2-(2-Aminothioazol-4-yl)-2-(1-carboxy-1-methyl) ethoxyiminoacetamido)-3-(3-hydroxy-4-pyridon-1-yl)methyl-3-cephem-4- carboxylic Acid and Related Compounds.
8. ChemInform Abstract: Synthetic Cephalosporins. Part 7. Synthesis and Antibacterial Activity of 7-(Z-(2-(2-Aminothiazol-4-yl)-2-(3-hydroxy-4-pyridon-1-yl)-3- carboxypropoxyimino)acetamido)-3-(1,2,3-thiazol-5-yl)thiomethyl-3- cephem-4-carboxylic Acid and It
9. In-vitro and in-vivo antimicrobial activities of a novel cephalosporin derivative, CP6162, possessing a dihydroxypyridone moiety at the C-3 side chain.
10. CP6679, a new injectable cephalosporin. Part1: Synthesis and structure-activity relationships
11. Penicillin-insensitive incorporation of D-amino acids into cell wall peptidoglycan influences the amount of bound lipoprotein in Escherichia coli
12. ChemInform Abstract: 7α-Methoxylation of Cephalosporins.
13. Radially-polarized, Q-switched pulses from a side-pumped Nd:YVO4 compact stigmatic bounce laser with a photonic crystal output coupler.
14. ChemInform Abstract: Synthetic Cephalosporins. Part 7. Synthesis and Antibacterial Activity of 7-(Z-(2-(2-Aminothiazol-4-yl)-2-(3-hydroxy-4-pyridon-1-yl)-3- carboxypropoxyimino)acetamido)-3-(1,2,3-thiazol-5-yl)thiomethyl-3- cephem-4-carboxylic Acid and Its Related Compounds.
15. ChemInform Abstract: Synthetic Cephalosporins. Part 6. Synthesis and Antibacterial Activity of 7-(Z-2-(2-Aminothioazol-4-yl)-2-(1-carboxy-1-methyl) ethoxyiminoacetamido)-3-(3-hydroxy-4-pyridon-1-yl)methyl-3-cephem-4- carboxylic Acid and Related Compounds.
16. Challenges to Acute Aortic Dissection in a Regional Hospital.
17. Impact of iodide ions on the speciation of radiolytic transients in molten LiCl-KCl eutectic salt mixtures.
18. Radiation-induced reaction kinetics of Zn 2+ with e S - and Cl 2 ˙ - in Molten LiCl-KCl eutectic at 400-600 °C.
19. Fluid Layered Ferroelectrics with Global C ∞v Symmetry.
20. Gamma radiation-induced defects in KCl, MgCl 2 , and ZnCl 2 salts at room temperature.
21. Design and performance of high-temperature furnace and cell holder for in situ spectroscopic, electrochemical, and radiolytic investigations of molten salts.
22. Versatile compact heater design for in situ nano-tomography by transmission X-ray microscopy.
23. Long-Term Imatinib Treatment for Patients with Unresectable or Recurrent Gastrointestinal Stromal Tumors.
24. Effect of a cardiac rehabilitation program on exercise oscillatory ventilation in Japanese patients with heart failure.
25. Impaired Swallowing in Hospitalized Patients: An Observational Study in a Community Hospital in Japan (2012-2014).
26. Which has the stronger impact on coronary artery disease, eicosapentaenoic acid or docosahexaenoic acid?
27. System for measuring temporal profiles of scintillation at high and different linear energy transfers by using pulsed ion beams.
28. Synthesis of novel di- and tricationic carbapenems with potent anti-MRSA activity.
29. CP5484, a novel quaternary carbapenem with potent anti-MRSA activity and reduced toxicity.
30. Synthesis and SAR study of novel 7-(pyridinium-3-yl)-carbonyl imidazo[5,1-b]thiazol-2-yl carbapenems.
31. CP0569, a new broad-spectrum injectable carbapenem. Part 1: synthesis and structure-activity relationships.
32. CP6679, a new injectable cephalosporin. Part 1: synthesis and structure-activity relationships.
33. Novel cephalosporin derivatives possessing a bicyclic heterocycle at the 3-position. Part II: Synthesis and antibacterial activity of 3-(5-methylthiazolo[4,5-c]pyridinium-2-yl)-thiomethylcephalosporin derivatives and related compounds.
34. Novel cephalosporin derivatives possessing a bicyclic heterocycle at the 3-position. Part I: Synthesis and biological activities of 3-(benzothiazol-2-yl)thiocephalosporin derivatives, CP0467 and related compounds.
35. CP2289, a new 5-HT3 receptor ligand: agonistic activities on gastroenteric motility.
36. Synthetic cephalosporins. VIII. Synthesis and antibacterial activity of CP6232, a new anti-pseudomonal cephalosporin.
37. Synthetic cephalosporins. VII. Synthesis and antibacterial activity of 7-[(Z)-2-(2-aminothiazol-4-yl)-2-(3-(3-hydroxy-4-pyridon-1-yl)-3- carboxypropoxyimino)acetamido]-3-(1,2,3-thiadiazol-5-yl)-thiomethyl-3- cephem-4-carboxylic acid and its related compounds.
38. A new antipseudomonal cephalosporin CP6162 and its congeners.
39. Synthesis and biological activity of (cyclopentenopyridinium) thiomethylcephalosporins.
40. Synthetic cephalosporins. VI. Synthesis and antibacterial activity of 7-[(Z)-2-(2-aminothiazol-4-yl)-2-(1-carboxy-1-methyl) ethoxyiminoacetamido]- 3-(3-hydroxy-4-pyridon-1-yl)methyl-3-cephem-4-carboxylic acid and related compounds.
41. New aminothiazolylglycylcephalosporins with a 1,5-dihydroxy-4-pyridone-2-carbonyl group. II. Synthesis and antibacterial activity of MT0703 and its diastereomers.
42. New aminothiazolylglycylcephalosporins with a 1,5-dihydroxy-4-pyridone-2-carbonyl group. I. Synthesis and biological activity of cephalosporin derivatives leading to MT0703.
43. In vitro antimicrobial activity of a novel aminothiazolylglycylcephalosporin, MT0703S, compared with that of ceftazidime, cefoperazone and aztreonam.
44. Discovery, isolation and structure of novel cephamycins of Streptomyces chartreusis.
45. Structure-activity relationships on the terminal D-amino acid moiety of a novel cephamycin MT-141.
46. Oligostatins, new antibiotics with amylase inhibitory activity. I. Production, isolation and characterization.
47. Oligostatins, new antibiotics with amylase inhibitory activity, II. Structures of oligostatins C, D, and E.
48. An analysis of the 1H and 13C NMR spectra of the macrolide antibiotic, neoisomidecamycin.
49. Modification of the macrolide antibiotic midecamycin. III. Formation of neoisomidecamycin.
50. Modifications of a macrolide antibiotic midecamycin. II. Reaction of midecamycin and 9-acetylmidecamycin with dimethylsulfoxide and acetic anhydride.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.